New pill aims to stop hair loss from lichen planopilaris
Disease control
Recruiting now
This study tests an oral medication called brepocitinib for adults with lichen planopilaris, a condition that causes scarring hair loss. About 342 participants will receive either the drug or a placebo to see if it reduces symptoms and improves scalp appearance. The goal is to co…
Phase: PHASE2, PHASE3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 07:36 UTC